
Sign up to save your podcasts
Or
Cytokine/Chemokine-expressing Oncolytic Virus
Genetic therapies, such as transfected viral vectors and immune cells, continue to display clinical responses as systemically deliverable and targeted therapeutics, with the first such strategy having been approved for cancer treatment. Most of these use cytokine transgenes.
Cytokine/Chemokine-expressing Oncolytic Virus
Genetic therapies, such as transfected viral vectors and immune cells, continue to display clinical responses as systemically deliverable and targeted therapeutics, with the first such strategy having been approved for cancer treatment. Most of these use cytokine transgenes.